Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.

× No keyword cloud information.

10 in total

Review 1. Hair disorders in patients with cancer.

Authors: Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal: J Am Acad Dermatol Date: 2018-04-14 Impact factor: 11.527

Review 2. Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors.

Authors: Francesco Facchinetti; Antoine Hollebecque; Rastislav Bahleda; Yohann Loriot; Ken A Olaussen; Christophe Massard; Luc Friboulet
Journal: Clin Cancer Res Date: 2019-10-04 Impact factor: 12.531

3. Metastatic Calcinosis Cutis Secondary to Selective Fibroblast Growth Factor Receptor Inhibitor: Rapid and Complete Regression after Blood Phosphate Normalization and Drug Withdrawal.

Authors: Daniel Lopez-Castillo; Alvaro March-Rodriguez; Alejo Rodriguez-Vida; Ramon M Pujol; Sonia Segura
Journal: Acta Derm Venereol Date: 2020-03-12 Impact factor: 3.875

Review 4. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.

Authors: Melanie A Krook; Julie W Reeser; Gabrielle Ernst; Hannah Barker; Max Wilberding; Gary Li; Hui-Zi Chen; Sameek Roychowdhury
Journal: Br J Cancer Date: 2020-12-03 Impact factor: 7.640

Review 5. Cutaneous toxicities from targeted therapies used in oncology: Literature review of clinical presentation and management.

Authors: Solène Huynh Dagher; Astrid Blom; Hedi Chabanol; Elisa Funck-Brentano
Journal: Int J Womens Dermatol Date: 2021-09-28

Review 10. Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.

Authors: Mario E Lacouture; Vincent Sibaud; Milan J Anadkat; Benjamin Kaffenberger; Jonathan Leventhal; Kathleen Guindon; Ghassan Abou-Alfa
Journal: Oncologist Date: 2020-10-28 Impact factor: 5.837

10 in total

Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.

Review 1. Hair disorders in patients with cancer.

Review 2. Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors.

3. Metastatic Calcinosis Cutis Secondary to Selective Fibroblast Growth Factor Receptor Inhibitor: Rapid and Complete Regression after Blood Phosphate Normalization and Drug Withdrawal.

Review 4. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.

Review 5. Cutaneous toxicities from targeted therapies used in oncology: Literature review of clinical presentation and management.

Review 6. FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma.

Review 7. Restorative oncodermatology: Diagnosis and management of dermatologic sequelae from cancer therapies.

Review 8. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.

Review 9. Dermatologic conditions in women receiving systemic cancer therapy.

Review 10. Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.